An article published today by the Washington Post suggests pharmaceutical companies may be increasing their focus on orphan drugs and treatments for rare diseases, leaving governments to foot the bill for…

A blog post published today on ModernHealthCare.com asks whether the US government’s shutdown of Megaupload could have implications for other cloud-based services, including healthcare applications.

Nature reports that players of Foldit, a protein modeling game, have produced what is being called “the first crowdsourced redesign of a protein”. The community is working on other puzzles that could…

An article in the “Big Issues: Health Care” series by the Wall Street Journal presents two opposing views of the role patents play in supporting ongoing research and development. Differing opinions…

The Patient-Centered Outcomes Research Institute, which was established by Congress as part of the Patient Protection and Affordable Care Act of 2010, has drafted a national agenda for research to…

The GoozNews blog notes the annual cost of new chemotherapeutic agents that received FDA approval during 2011 ranges from $44,000 to $216,000. Part of the problem, according to the pharmaceutical industry, is that…

The New York Times ran a story last week about the discovery of artemisinin. A GoozNews post from 2007 explored the clinical development of the drug in depth.

FDA’s Office of Pediatric Therapeutics is offering a public workshop examining the need for pediatric research to inform the development of public health strategies. The workshop will take place February…